BioHealth News Archive
Why doctors won’t stop PSA testing anytime soon
Johns Hopkins researchers say it’s going to be a hard sell to get physicians to stop screening healthy men routinely for prostate cancer with…
Read More
InvestMaryland Forum
Thursday, June 14, 2012 from 10:00 AM to 12:00 PM (ET)Rockville, MD A free and open forum to: Discuss InvestMaryland implementation progress and investment…
Read More
The “Valley of Death” Looms for 8 Kids with a Rare Disease | Guest Blog, Scientific American Blog Network
The pharmaceutical industry rightly calls the stage in drug development between basic research and clinical trials the “Valley of Death.” This is when a…
Read More
2012 BIO International Convention – Boston
Thousands of companies from around the world and all industry segments will be at BIO, ready to build strategic partnerships. Attend the Global Event…
Read More
Fulfilling the promise of bioscience: report from Milken Institute outlines steps for overcoming barriers to innovation in medical research
It's been almost a decade since the Human Genome Project was completed, yet despite the best efforts of thousands of scientists around the world,…
Read More
Events: Boston by the Numbers
BIO International Convention organizers are hoping for the usual surge in attendance provided by the Boston biotech community at the event scheduled for June…
Read More
Want Better Odds? Get a Pharma Corporate VC to Invest – Forbes
Pharma corporate venture was back in the biotech news today with the release of Burrill & Company’s June 2012 report. An interesting article by Vinay…
Read More
Rockville Economic Development Inc. appoints executive director
Laurie Boyer, president of the Maryland Economic Development Association, is the new executive director of Rockville Economic Development Inc. Boyer has more than 15…
Read More
BioPulse – New cancer center breaks ground
The State of Maryland's Pulse on the Bio Industry. {iframe}http://cl.publicaster.com/ViewInBrowser.aspx?pubids=7297%7c810%7c88281%7c72143&digest=IxuSUfKR0eryi579dsIj3g&sysid=1{/iframe}
Read More
Who’s on Biotech’s Endangered Species List? Mid-Sized Drug Developers | Xconomy
Only a few companies have ever been successful enough to call themselves Big Biotechs. If boards and shareholders lack vision and guts, we’ll look back…
Read More
Cleveland Clinic to help Notre Dame commercialize medical innovations
Following on the heels of two hospitals, the University of Notre Dame has become the first university to strike a collaboration with Cleveland Clinic…
Read More
Osiris becomes first company to market stem-cell therapy – Baltimore Business Journal
Osiris Therapeutics Inc. in Columbia has become the world’s first company to receive market approval for a manufactured stem cell product. Health Canada, the…
Read More
Emergent gets FDA approval for modified vaccine dosing – Washington Business Journal
Rockville-based Emergent BioSolutions Inc. , which makes the only vaccine licensed by the Food and Drug Administration to protect against anthrax infection, has received…
Read More
United Therapeutics to Own Even More of Downtown Silver Spring
United Therapeutics, which has has greatly expanded their downtown Silver Spring presence as of late, is reportedly set to purchase from the county the…
Read More
Human Genome Sciences adopts stockholder rights plan – Baltimore Business Journal
Human Genome Sciences Inc, which has rejected a hostile $13-per-share offer from GlaxoSmithKline, has adopted a short-term stockholder rights plan to fend off such…
Read More